New Screening Opportunity for RhD Negative and Alloimmunized Pregnant Individuals

March 12 marks World Alloimmunization and Hemolytic Disease of the Fetus and Newborn (HDFN) Awareness Day, a global initiative to increase awareness and advocate for patients impacted by, and providers managing, Alloimmunization and HDFN.

Ontario is making significant progress in this area with the implementation of two new screening tests to assess for fetal blood group incompatibility in pregnancy. This advancement will enhance prenatal care by offering timely information to support the decision-making of health-care providers and their patients.

What You Need to Know

Have questions? Find out:
✔ What tests will be available?
✔ Who is eligible for testing?
✔ What benefits are provided by this test?

Fetal Blood Group Genotyping in Ontario

Background report: Health Quality Ontario's Health Technology Assessment